NSCLC Patient Tool
Treatment Options From 5 Experts for People With Unresectable Stage III or Metastatic NSCLC: An Online Tool

Released: October 02, 2020

Expiration: October 01, 2021

About This Tool & Disclaimer

Treatment Options From 5 Experts for People With Unresectable Stage III or Metastatic NSCLC: An Online Tool

Clinical Care Options, LLC, is grateful to expert faculty Matthew Gubens, MD, MS; Leora Horn, MD, MSc, FACP; Melissa L. Johnson, MD; Karen L. Reckamp, MD; and H. Jack West, MD, who provided expert guidance, knowledge, and support in the development of this Interactive Decision Support Tool.

Note: These data were compiled in May 2020 and include the opinions of the experts at that time.

The goal of this tool is to help you better understand your diagnosis of locally advanced or metastatic NSCLC, to better understand your treatment options, and to become partners with the oncology team instead of being a bystander in your cancer care.

A series of questions developed by the experts allow you to select information about yourself and your cancer that are necessary to consider when making treatment choices in advanced NSCLC. These characteristics include:

  • Disease stage
  • Tumor histology
  • Presence of specific tumor markers
  • Presence of brain metastases
  • Previous therapy received
  • Age
  • Overall fitness
  • Your primary goal for outcome of treatment

If you do not have this information yet, you can ask your oncologist about these characteristics—sometimes it helps to have someone attend appointments with you to take notes or you can ask your oncologist if it is ok to record the conversation (most are fine with and used to being recorded). We also developed a PDF checklist that you can print and take with you to your appointment to help you gather this information.

It should be noted that these factors are not the only things to consider when making choices about your treatment; other health issues (comorbidities) and disease characteristics that cannot be included in this tool also need to be considered and discussed with your oncologist to create the best plan for your individual needs.

Once the information is entered, you will be asked to enter the treatment plan your team has suggested. Select the answer option “uncertain” if a plan has yet to be made. Afterward, you will see an Expert Insight table showing the treatment choices of all 5 experts based on the characteristics you entered. It should be noted that there may not be a unanimous choice among the experts, which serves to show that there is typically more than one good option in many instances for individual people. This gives you and your team the opportunity to choose the best care for you.

You can print the expert choices along with a summary of the characteristics and selected therapy you entered by clicking Case Summary.

This program is supported by educational grants from Bristol-Myers Squibb, Celgene, and LOXO Oncology.

© 2020 Clinical Care Options, LLC. All rights reserved.

Disclaimer: Access to and use of this Interactive Decision Support Tool titled, “Treatment Options From 5 Experts for People With Unresectable Stage III or Metastatic NSCLC: An Online Tool,” is provided subject to the following terms and conditions. PLEASE READ THESE TERMS CAREFULLY.

This Interactive Decision Support Tool is designed to educate patients on potential treatments for unresectable stage III and metastatic NSCLC. The information provided is based on the expert guidance of lung cancer experts Matthew Gubens, MD, MS; Leora Horn, MD, MSc, FACP; Melissa L. Johnson, MD; Karen L. Reckamp, MD; and H. Jack West, MD.

The material published by Clinical Care Options reflects the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the FDA. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before using any therapies described in these materials.

Although the information contained in the “Treatment Options From 5 Experts for People With Unresectable Stage III or Metastatic NSCLC: An Online Tool” Interactive Decision Support Tool has been produced and processed from sources believed to be reliable, no warranty, expressed or implied, is made regarding the accuracy, adequacy, completeness, legality, reliability, or usefulness of any information. This disclaimer applies to both the isolated and aggregate uses of the information. Clinical Care Options provides this information on an as-is basis. This disclaimer applies to all material published by Clinical Care Options including but not limited to medical information or opinions. All warranties of any kind, expressed or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose, freedom from contamination by computer viruses, and noninfringement of proprietary rights are disclaimed.

Any trademarks are the property of respective companies.

© 2020 Clinical Care Options, LLC. All rights reserved.

Program Content